The use of nanoparticles for gene therapy in the nervous system

Journal of Alzheimer's Disease

Volumn 31, Issue 4, 2012, Pages 697-710

  Pérez Martínez, Francisco C ^c   Carrión, Blanca ^c   Cea, Valentín ^a,b  

^a UNIVERSITY OF CASTILLA LA MANCHA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c NanoDrugs   (Spain)

Author keywords

Blood brain barrier; dendrimers; gene transfer; nanoparticles; neurons; siRNA

Indexed keywords

CHITOSAN; CLATHRIN; COLLAGEN; DENDRIMER; DNA; LIPID; LIPOSOME; NANOMATERIAL; NANOPARTICLE; POLYAMIDOAMINE; POLYETHYLENEIMINE DERIVATIVE; RNA; SILICON DIOXIDE;

BIOCOMPATIBILITY; BLOOD BRAIN BARRIER; CELL MEMBRANE PERMEABILITY; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; ENDOCYTOSIS; ENDOSOME; GENE DELIVERY SYSTEM; GENE THERAPY; GENETIC TRANSFECTION; IN VITRO STUDY; IN VIVO STUDY; MICELLE; MOLECULAR SIZE; NERVE CELL; NERVE CELL NETWORK; NERVE FIBER TRANSPORT; PH; PRIORITY JOURNAL; RETICULOENDOTHELIAL SYSTEM; REVIEW; SOLID; TRANSCYTOSIS;

EID: 84866315959     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2012-120661     Document Type: Review

References (141)

1. Posadas I, Guerra FJ, Ceña V (2010) Nonviral vectors for the delivery of small interfering RNAs to the CNS. Nanomedicine (Lond) 5, 1219-1236.
2. Morrison RS,Wenzel HJ, Kinoshita Y, Robbins CA, Donehower LA, Schwartzkroin PA (1996) Loss of the p53 tumor suppressor gene protects neurons from kainate-induced cell death. J Neurosci 16, 1337-1345.
3. Christophorou MA, Martin-Zanca D, Soucek L, Lawlor ER, Brown-Swigart L, Verschuren EW, Evan GI (2005) Temporal dissection of p53 function in vitro and in vivo. Nat Genet 37, 718-726.
4. Fernandez M, Segura MF, Sole C, Colino A, Comella JX, Ceña V (2007) Lifeguard/neuronal membrane protein 35 regulates Fas ligand-mediated apoptosis in neurons via microdomain recruitment. J Neurochem 103, 190-203.
5. Xiao X, Li J, Samulski RJ (1996) Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector. J Virol 70, 8098-8108.
6. Chirmule N, Xiao W, Truneh A, Schnell MA, Hughes JV, Zoltick P, Wilson JM (2000) Humoral immunity to adenoassociated virus type 2 vectors following administration to murine and nonhuman primate muscle. J Virol 74, 2420-2425.
7. Olsen NJ, SteinCM(2004) Newdrugs for rheumatoid arthritis. N Engl J Med 350, 2167-2179.
8. Hollon T (2000) Researchers and regulators reflect on first gene therapy death. Nat Med 6, 6-10.
9. Verma IM (2000) A tumultuous year for gene therapy. Mol Ther 2, 415-416.
10. Check E (2005) Gene therapy put on hold as third child develops cancer. Nature 433, 561-564.
11. Kulkarni M, Greiser U, O'Brien T, Pandit A (2010) Liposomal gene delivery mediated by tissue-engineered scaffolds. Trends Biotechnol 28, 28-36.
12. Breunig M, Bauer S, Goepferich A (2008) Polymers and nanoparticles: Intelligent tools for intracellular targeting? Eur J Pharm Biopharm 68, 112-128.
13. Itaka K, Kataoka K (2009) Recent development of nonviral gene delivery systems with virus-like structures and mechanisms. Eur J Pharm Biopharm 71, 475-483.
14. Medina SH, El-SayedME(2009) Dendrimers as carriers for delivery of chemotherapeutic agents. Chem Rev 109, 3141-3157.
15. P'erez-Martínez FC, Guerra J, Posadas I, Ceña V (2011) Barriers to non-viral vector-mediated gene delivery in the nervous system. Pharm Res 28, 1843-1858.
16. Yang H (2010) Nanoparticle-mediated brain-specific drug delivery, imaging, and diagnosis. Pharm Res 27, 1759-1771.
17. Faraji AH, Wipf P (2009) Nanoparticles in cellular drug delivery. Bioorg Med Chem 17, 2950-2962.
18. Misra A, Ganesh S, Shahiwala A, Shah SP (2003) Drug delivery to the central nervous system: A review. J Pharm Pharm Sci 6, 252-273.
19. Crone C, Christensen O (1981) Electrical resistance of a capillary endothelium. J Gen Physiol 77, 349-371.
20. Rubin LL, Staddon JM (1999) The cell biology of the bloodbrain barrier. Annu Rev Neurosci 22, 11-28.
21. Kotze AF, Luessen HL, de Leeuw BJ, de Boer AG, Verhoef JC, Junginger HE (1998) Comparison of the effect of different chitosan salts and N-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2). J Control Release 51, 35-46.
22. Adamson RH, Lenz JF, Zhang X, Adamson GN,Weinbaum S, Curry FE (2004) Oncotic pressures opposing filtration across non-fenestrated rat microvessels. J Physiol 557, 889-907.
23. Huang R,KeW, Han L, LiuY, Shao K, Jiang C, PeiY(2010) Lactoferrin-modified nanoparticles could mediate efficient gene delivery to the brain in vivo. Brain Res Bull 81, 600-604.
24. Ke W, Shao K, Huang R, Han L, Liu Y, Li J, Kuang Y, Ye L, Lou J, Jiang C (2009) Gene delivery targeted to the brain using an Angiopep-conjugated polyethyleneglycolmodified polyamidoamine dendrimer. Biomaterials 30, 6976-6985.
25. Huang RQ, Qu YH, Ke WL, Zhu JH, Pei YY, Jiang C (2007) Efficient gene delivery targeted to the brain using a transferrin-conjugated polyethyleneglycol-modified polyamidoamine dendrimer. FASEB J 21, 1117-1125.
26. Lockman PR, Oyewumi MO, Koziara JM, Roder KE, Mumper RJ, Allen DD (2003) Brain uptake of thiaminecoated nanoparticles. J Control Release 93, 271-282.
27. Aktas Y, Yemisci M, Andrieux K, Gursoy RN, Alonso MJ, Fernandez-Megia E, Novoa-Carballal R, Quinoa E, Riguera R, Sargon MF, Celik HH, Demir AS, Hincal AA, Dalkara T, Capan Y, Couvreur P (2005) Development and brain delivery of chitosan-PEG nanoparticles functionalized with the monoclonal antibody OX26. Bioconjug Chem 16, 1503-1511.
28. Brigger I, Morizet J, Aubert G, Chacun H, Terrier-Lacombe MJ, Couvreur P, Vassal G (2002) Poly(ethylene glycol)-coated hexadecylcyanoacrylate nanospheres display a combined effect for brain tumor targeting. J Pharmacol Exp Ther 303, 928-936.
29. Kreuter J (2001) Nanoparticulate systems for brain delivery of drugs. Adv Drug Deliv Rev 47, 65-81.
30. Lee HJ, Engelhardt B, Lesley J, Bickel U, Pardridge WM (2000) Targeting rat anti-mouse transferrin receptor monoclonal antibodies through blood-brain barrier in mouse. J Pharmacol Exp Ther 292, 1048-1052.
31. Dhanikula RS, Argaw A, Bouchard JF, Hildgen P (2008) Methotrexate loaded polyether-copolyester dendrimers for the treatment of gliomas: Enhanced efficacy and intratumoral transport capability. Mol Pharm 5, 105-116.
32. Lafon M (2005) Rabies virus receptors. J Neurovirol 11, 82-87.
33. Dou H, Morehead J, Destache CJ, Kingsley JD, Shlyakhtenko L, Zhou Y, Chaubal M, Werling J, Kipp J, Rabinow BE, Gendelman HE (2007) Laboratory investigations for the morphologic, pharmacokinetic, and anti-retroviral properties of indinavir nanoparticles in human monocyte-derived macrophages. Virology 358, 148-158.
34. Suk JS, Suh J, Lai SK, Hanes J (2007) Quantifying the intracellular transport of viral and nonviral gene vectors in primary neurons. Exp Biol Med (Maywood) 232, 461-469.
35. Rejman J, Oberle V, Zuhorn IS, Hoekstra D (2004) Sizedependent internalization of particles via the pathways of clathrin-and caveolae-mediated endocytosis. Biochem J 377, 159-169.
36. Lakadamyali M, Rust MJ, Zhuang X (2006) Ligands for clathrin-mediated endocytosis are differentially sorted into distinct populations of early endosomes. Cell 124, 997-1009.
37. Boussif O, Lezoualc'h F, ZantaMA,MergnyMD, Scherman D, Demeneix B, Behr JP (1995) A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: Polyethylenimine. Proc Natl Acad Sci U S A 92, 7297-7301.
38. Ohki EC, Tilkins ML, Cice VC, Price PJ (2001) Improving the transfection efficiency of post-mitotic neurons. J Neurosci Methods 112, 95-99.
39. P'erez-Carri'on MD, P'erez-Martínez FC, Merino S, Sánchez-Verd'u P, Martínez-Hernández J, Luján R, Ceña V (2012) Dendrimer-mediated siRNA delivery knocks down Beclin 1 and potentiates NMDA-mediated toxicity in rat cortical neurons. J Neurochem 120, 259-268.
40. Neu M, Fischer D, Kissel T (2005) Recent advances in rational gene transfer vector design based on poly(ethylene imine) and its derivatives. J Gene Med 7, 992-1009.
41. Kleemann E, Neu M, Jekel N, Fink L, Schmehl T, Gessler T, Seeger W, Kissel T (2005) Nano-carriers for DNA delivery to the lung based upon a TAT-derived peptide covalently coupled to PEG-PEI. J Control Release 109, 299-316.
42. Sethuraman VA, Bae YH (2007) TAT peptide-based micelle system for potential active targeting of anti-cancer agents to acidic solid tumors. J Control Release 118, 216-224.
43. Torchilin VP (2006) Recent approaches to intracellular delivery of drugs and DNA and organelle targeting. Annu Rev Biomed Eng 8, 343-375.
44. Harush-Frenkel O, Debotton N, Benita S, Altschuler Y (2007) Targeting of nanoparticles to the clathrin-mediated endocytic pathway. Biochem Biophys Res Commun 353, 26-32.
45. Gillies ER, Goodwin AP, Frechet JM (2004) Acetals as pHsensitive linkages for drug delivery. Bioconjug Chem 15, 1254-1263.
46. Ropert C, Malvy C, Couvreur P (1993) Inhibition of the Friend retrovirus by antisense oligonucleotides encapsulated in liposomes: Mechanism of action. Pharm Res 10, 1427-1433.
47. Roy I,Mitra S, Maitra A, Mozumdar S (2003) Calcium phosphate nanoparticles as novel non-viral vectors for targeted gene delivery. Int J Pharm 250, 25-33.
48. Armatas GS, KanatzidisMG(2006) Mesostructured germanium with cubic pore symmetry. Nature 441, 1122-1125.
49. Trikalitis PN, Rangan KK, Bakas T, Kanatzidis MG (2001) Varied pore organization in mesostructured semiconductors based on the
50. Zou X, Conradsson T, Klingstedt M, Dadachov MS, O'Keeffe M (2005) A mesoporous germanium oxide with crystalline pore walls and its chiral derivative. Nature 437, 716-719.
51. Areva S, Aaritalo V, Tuusa S, Jokinen M, Linden M, Peltola T (2007) Sol-Gel-derived TiO2-SiO2 implant coatings for direct tissue attachment. Part II: Evaluation of cell response. J Mater Sci Mater Med 18, 1633-1642.
52. LaiCY, Trewyn BG, JeftinijaDM,Jeftinija K, Xu S, Jeftinija S, Lin VS (2003) A mesoporous silica nanosphere-based carrier system with chemically removable CdS nanoparticle caps for stimuli-responsive controlled release of neurotransmitters and drug molecules. J Am Chem Soc 125, 4451-4459.
53. Zhu MQ, Han JJ, Li AD (2007) CdSe/CdS/SiO2 core/shell/shell nanoparticles. J Nanosci Nanotechnol 7, 432-439.
54. Dormer K, Seeney C, Lewelling K, Lian G, Gibson D, Johnson M (2005) Epithelial internalization of superparamagnetic nanoparticles and response to external magnetic field. Biomaterials 26, 2061-2072.
55. Corso TD, Torres G, Goulah C, Roy I, Gambino AS, Nayda J, Buckley T, Stachowiak EK, Bergey EJ, Pudavar H, Dutta P, Bloom DC, Bowers WJ, Stachowiak MK (2005) Assessment of viral and non-viral gene transfer into adult rat brains using HSV-1, calcium phosphate and PEI-based methods. Folia Morphol (Warsz) 64, 130-144.
56. Slowing II, Vivero-Escoto JL, Wu CW, Lin VS (2008) Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv Drug Deliv Rev 60, 1278-1288.
57. Jeffery ND, McBain SC, Dobson J, Chari DM (2009) Uptake of systemically administered magnetic nanoparticles (MNPs) in areas of experimental spinal cord injury (SCI). J Tissue Eng Regen Med 3, 153-157.
58. Estevanato L, Cintra D, Baldini N, Portilho F, Barbosa L, Martins O, Lacava B, Miranda-Vilela AL, Tedesco AC, Bao S, Morais PC, Lacava ZG (2011) Preliminary biocompatibility investigation of magnetic albumin nanosphere designed as a potential versatile drug delivery system. Int J Nanomedicine 6, 1709-1717.
59. Wong HL, Chattopadhyay N, Wu XY, Bendayan R (2010) Nanotechnology applications for improved delivery of antiretroviral drugs to the brain. Adv Drug Deliver Rev 62, 503-517.
60. Lai WF, Lin MC (2009) Nucleic acid delivery with chitosan and its derivatives. J Control Release 134, 158-168.
61. Kim TH, Jiang HL, Nah JW, Cho MH, Akaike T, Cho CS (2007) Receptor-mediated gene delivery using chemically modified chitosan. Biomed Mater 2, S95-S100.
62. Sano A, Maeda M, Nagahara S, Ochiya T, Honma K, Itoh H, Miyata T, Fujioka K (2003) Atelocollagen for protein and gene delivery. Adv Drug Deliv Rev 55, 1651-1677.
63. Felgner PL, Gadek TR, Holm M, Roman R, ChanHW,Wenz M, Northrop JP, Ringold GM, DanielsenM(1987) Lipofection: A highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci U S A 84, 7413-7417.
64. Behr JP, Demeneix B, Loeffler JP, P'erez-Mutul J (1989) Efficient gene transfer into mammalian primary endocrine cells with lipopolyamine-coated DNA. Proc Natl Acad Sci U S A 86, 6982-6986.
65. Guerra-Crespo M, Charli JL, Rosales-García VH, Pedraza-Alva G, P'erez-Martínez L (2003) Polyethylenimine improves the transfection efficiency of primary cultures of post-mitotic rat fetal hypothalamic neurons. J Neurosci Methods 127, 179-192.
66. Ryman BE, Jewkes RF, Jeyasingh K, Osborne MP, Patel HM, Richardson VJ, Tattersall MH, Tyrrell DA (1978) Potential applications of liposomes to therapy. AnnNY Acad Sci 308, 281-307.
67. Bangham AD (1995) Surrogate cells or Trojan horses. The discovery of liposomes. Bioessays 17, 1081-1088.
68. Schnyder A, Huwyler J (2005) Drug transport to brain with targeted liposomes. NeuroRx 2, 99-107.
69. Torchilin VP (2008) Tat peptide-mediated intracellular delivery of pharmaceutical nanocarriers. Adv Drug Deliv Rev 60, 548-558.
70. Cardoso AL, Costa P, de Almeida LP, Simoes S, Plesnila N, Culmsee C, Wagner E, Pedroso de Lima MC (2009) Tf-lipoplex-mediated c-Jun silencing improves neuronal survival following excitotoxic damage in vivo. J Control Release 109, 392-403.
71. Lockman PR, Oyewumi MO, Koziara JM, Roder KE, Mumper RJ, Allen DD (2003) Brain uptake of thiaminecoated nanoparticles. J Control Release 93, 271-282.
72. Holt CE, Garlick N, Cornel E (1990) Lipofection of cDNAs in the embryonic vertebrate central nervous system. Neuron 4, 203-214.
73. Imaoka T, Date I, Ohmoto T, Nagatsu T (1998) Significant behavioral recovery in Parkinson's disease model by direct intracerebral gene transfer using continuous injection of a plasmid DNA-liposome complex. Hum Gene Ther 9, 1093-1102.
74. Zhang Y, Schlachetzki F, Zhang YF, Boado RJ, Pardridge WM (2004) Normalization of striatal tyrosine hydroxylase and reversal of motor impairment in experimental parkinsonism with intravenous nonviral gene therapy and a brain-specific promoter. Hum Gene Ther 15, 339-350.
75. Zou LL, Huang L, Hayes RL, Black C, Qiu YH, Perez-Polo JR, LeW, Clifton GL,YangK(1999) Liposomemediated NGF gene transfection following neuronal injury: Potential therapeutic applications. Gene Ther 6, 994-1005.
76. da CruzMT, Cardoso AL, de Almeida LP, Simoes S, de Lima MC (2005) Tf-lipoplex-mediated NGF gene transfer to the CNS: Neuronal protection and recovery in an excitotoxic model of brain injury. Gene Ther 12, 1242-1252.
77. Zhang Y, Jeong LH, Boado RJ, Pardridge WM (2002) Receptor-mediated delivery of an antisense gene to human brain cancer cells. J Gene Med 4, 183-194.
78. Zhang Y, Zhang YF, Bryant J, Charles A, Boado RJ, Pardridge WM (2004) Intravenous RNA interference gene therapy targeting the human epidermal growth factor receptor prolongs survival in intracranial brain cancer. Clin Cancer Res 10, 3667-3677.
79. Boado RJ (2005) RNA interference and nonviral targeted gene therapy of experimental brain cancer. NeuroRx 2, 139-150.
80. Wissing SA, Kayser O, Muller RH (2004) Solid lipid nanoparticles for parenteral drug delivery. Adv Drug Deliv Rev 56, 1257-1272.
81. Harivardhan Reddy L, Sharma RK, Chuttani K, Mishra AK, Murthy RS (2005) Influence of administration route on tumor uptake and biodistribution of etoposide loaded solid lipid nanoparticles in Dalton's lymphoma tumor bearing mice. J Control Release 105, 185-198.
82. Manjunath K, Venkateswarlu V (2005) Pharmacokinetics, tissue distribution and bioavailability of clozapine solid lipid nanoparticles after intravenous and intraduodenal administration. J Control Release 107, 215-228.
83. MehnertW, Mader K (2001) Solid lipid nanoparticles: Production, characterization and applications. Adv Drug Deliv Rev 47, 165-196.
84. Troster SD, Kreuter J (1992) Influence of the surface properties of low contact angle surfactants on the body distribution of 14C-poly(methyl methacrylate) nanoparticles. J Microencapsul 9, 19-28.
85. Scholer N, Olbrich C, Tabatt K, Muller RH, Hahn H, Liesenfeld O (2001) Surfactant, but not the size of solid lipid nanoparticles (SLN) influences viability and cytokine production of macrophages. Int J Pharm 221, 57-67.
86. Peira E, Marzola P, Podio V, Aime S, Sbarbati A, GascoMR (2003) In vitro and in vivo study of solid lipid nanoparticles loaded with superparamagnetic iron oxide. J Drug Target 11, 19-24.
87. Koziara JM, Lockman PR, Allen DD, Mumper RJ (2004) Paclitaxel nanoparticles for the potential treatment of brain tumors. J Control Release 99, 19-24.
88. Abdallah B, Hassan A, Benoist C, Goula D, Behr JP, Demeneix BA (1996) A powerful nonviral vector for in vivo gene transfer into the adult mammalian brain: Polyethylenimine. Hum Gene Ther 7, 1947-1954.
89. Alyaudtin RN, Reichel A, Lobenberg R, Ramge P, Kreuter J, Begley DJ (2001) Interaction of poly(butylcyanoacrylate) nanoparticles with the blood-brain barrier in vivo and in vitro. J Drug Target 9, 209-221.
90. Gao K, JiangX(2006) Influence of particle size on transport of methotrexate across blood brain barrier by polysorbate 80-coated polybutylcyanoacrylate nanoparticles. Int J Pharm 310, 213-219.
91. Dechy-Cabaret O, Martin-Vaca B, BourissouD(2004) Controlled ring-opening polymerization of lactide and glycolide. Chem Rev 104, 6147-6176.
92. Leonard DJ, Pick LT, Farrar DF, Dickson GR, Orr JF, Buchanan FJ (2009) The modification of PLA and PLGA using electron-beam radiation. J Biomed Mater Res A 89, 567-574.
93. Dunlap DD, Maggi A, Soria MR, Monaco L (1997) Nanoscopic structure of DNA condensed for gene delivery. Nucleic Acids Res 25, 3095-3101.
94. Demeneix B, Hassani Z, Behr JP (2004) Towards multifunctional synthetic vectors. Curr Gene Ther 4, 445-455.
95. GodbeyWT,Wu KK, Mikos AG (1999) Poly(ethylenimine) and its role in gene delivery. J Control Release 60, 149-160.
96. Helander IM, Alakomi HL, Latva-Kala K, Koski P (1997) Polyethyleneimine is an effective permeabilizer of gramnegative bacteria. Microbiology 143, 3193-3199.
97. Kim JM, Lee M, Kim KH, Ha Y, Choi JK, Park SR, Park H, Park HC, Ahn CH, Kim SW, Choi BH (2009) Gene therapy of neural cell injuries in vitro using the hypoxiainducible GM-CSF expression plasmids and water-soluble lipopolymer (WSLP). J Control Release 133, 60-67.
98. Ogris M, Brunner S, Schuller S, Kircheis R, Wagner E (1999) PEGylated DNA/transferrin-PEI complexes: Reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery. Gene Ther 6, 595-605.
99. Park IK, Lasiene J, Chou SH, Horner PJ, Pun SH (2007) Neuron-specific delivery of nucleic acids mediated by Tet1-modified poly(ethylenimine). J Gene Med 9, 691-702.
100. Andreu A, Fairweather N, Miller AD (2008) Clostridium neurotoxin fragments as potential targeting moieties for liposomal gene delivery to the CNS. Chembiochem 9, 219-231.
101. Bergen JM, Park IK, Horner PJ, Pun SH (2008) Nonviral approaches for neuronal delivery of nucleic acids. Pharm Res 25, 983-998.
102. Bazile D, Prud'homme C, Bassoullet MT, Marlard M, Spenlehauer G, Veillard M (1995) Stealth Me. PEG-PLA nanoparticles avoid uptake by the mononuclear phagocytes system. J Pharm Sci 84, 493-498.
103. Peracchia MT, Vauthier C, Desmaele D, Gulik A, Dedieu JC, Demoy M, D'Angelo J, Couvreur P (1998) Pegylated nanoparticles from a novel methoxypolyethylene glycol cyanoacrylate-hexadecyl cyanoacrylate amphiphilic copolymer. Pharm Res 15, 550-556.
104. Calvo P, Gouritin B, Villarroya H, Eclancher F, Giannavola C, Klein C, Andreux JP, Couvreur P (2002) Quantification and localization of PEGylated polycyanoacrylate nanoparticles in brain and spinal cord during experimental allergic encephalomyelitis in the rat. Eur J Neurosci 15, 1317-1326.
105. Araujo L, Lobenberg R, Kreuter J (1999) Influence of the surfactant concentration on the body distribution of nanoparticles. J Drug Target 6, 373-385.
106. Blasi P, Giovagnoli S, Schoubben A, Ricci M, Rossi C (2007) Solid lipid nanoparticles for targeted brain drug delivery. Adv Drug Deliv Rev 59, 454-477.
107. Bandyopadhyay P, Ma X, Linehan-Stieers C, Kren BT, Steer CJ (1999) Nucleotide exchange in genomic DNA of rat hepatocytes usingRNA/ DNAoligonucleotides. Targeted delivery of liposomes and polyethyleneimine to the asialoglycoprotein receptor. J Biol Chem 274, 10163-10172.
108. IwaiM,HaradaY,Tanaka S, Muramatsu A, MoriT, Kashima K, Imanishi J, Mazda O (2002) Polyethylenimine-mediated suicide gene transfer induces a therapeutic effect for hepatocellular carcinoma in vivo by using an Epstein-Barr virus-based plasmid vector. Biochem Biophys Res Commun 291, 48-54.
109. Aigner A, Fischer D, Merdan T, Brus C, Kissel T, Czubayko F (2002) Delivery of unmodified bioactive ribozymes by an RNA-stabilizing polyethylenimine (LMW-PEI) efficiently down-regulates gene expression. Gene Ther 9, 1700-1707.
110. Lemkine GF, Goula D, Becker N, Paleari L, Levi G, Demeneix BA (1999) Optimisation of polyethyleniminebased gene delivery to mouse brain. J Drug Target 7, 305-312.
111. Goula D, Remy JS, Erbacher P, Wasowicz M, Levi G, Abdallah B, Demeneix BA (1998) Size, diffusibility and transfection performance of linear PEI/DNA complexes in the mouse central nervous system. Gene Ther 5, 712-717.
112. Shi L, Tang GP, Gao SJ, Ma YX, Liu BH, Li Y, Zeng JM, Ng YK, Leong KW, Wang S (2003) Repeated intrathecal administration of plasmid DNA complexed with polyethylene glycol-grafted polyethylenimine led to prolonged transgene expression in the spinal cord. Gene Ther 10, 1179-1188.
113. Tang GP, Guo HY, Alexis F, Wang X, Zeng S, Lim TM, Ding J, Yang YY, Wang S (2006) Low molecular weight polyethylenimines linked by beta-cyclodextrin for gene transfer into the nervous system. J Gene Med 8, 736-744.
114. Azzouz M, Ralph GS, Storkebaum E, Walmsley LE, Mitrophanous KA, Kingsman SM, Carmeliet P, Mazarakis ND (2004) VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model. Nature 429, 413-417.
115. Wang S, Ma N, Gao SJ, Yu H, Leong KW (2001) Transgene expression in the brain stem effected by intramuscular injection of polyethylenimine/DNA complexes. Mol Ther 3, 658-664.
116. Lee CC, MacKay JA, Frechet JM, Szoka FC (2005) Designing dendrimers for biological applications. Nat Biotechnol 23, 1517-1526.
117. Tang MX, Redemann CT, Szoka FC Jr (1996) In vitro gene delivery by degraded polyamidoamine dendrimers. Bioconjug Chem 7, 703-714.
118. Choi YS, Cho TS, Kim JM, HanSW, Kim SK (2006) Amine terminated G-6 PAMAM dendrimer and its interaction with DNA probed by Hoechst 33258. Biophys Chem 121, 142-149.
119. Abe H, Keen KL, Terasawa E (2008) Rapid action of estrogens on intracellular calcium oscillations in primate luteinizing hormone-releasing hormone-1 neurons. Endocrinology 149, 1155-1162.
120. An Y, Jiang X, Bi W, Chen H, Jin L, Zhang S, Wang C, Zhang W (2012) Sensitive electrochemical immunosensor for alpha-synuclein based on dual signal amplification using PAMAM dendrimer-encapsulated Au and enhanced gold nanoparticle labels. Biosens Bioelectron 32, 224-230.
121. Posadas I, L'opez-Hernández B, Clemente MI, Jim'enez JL, Ortega P, de la MJ, G'omez R, Muñoz-Fernández MA, Ceña V(2009) Highly efficient transfection of rat cortical neurons using carbosilane dendrimers unveils a neuroprotective role for HIF-1alpha in early chemical hypoxia-mediated neurotoxicity. Pharm Res 26, 1181-1191.
122. Kim JB, Choi JS, Nam K, Lee M, Park JS, Lee JK (2006) Enhanced transfection of primary cortical cultures using arginine-grafted PAMAMdendrimer, PAMAM-Arg. J Control Release 114, 110-117.
123. Kim TI, Bai CZ, Nam K, Park JS (2009) Comparison between arginine conjugated PAMAM dendrimers with structural diversity for gene delivery systems. J Control Release 136, 132-139.
124. Rodrigo AC, Rivilla I, P'erez-Martínez FC, Monteagudo S, Ocaña V, Guerra J, García-Martínez JC, Merino S, Sánchez-Verd'u P, Ceña V, Rodríguez-L'opez J (2011) Efficient, Non-Toxic Hybrid PPV-PAMAM Dendrimer as a Gene Carrier for Neuronal Cells. Biomacromolecules 12, 1205-1213.
125. Posadas I, P'erez-Martínez FC, Guerra J, Sánchez-Verd'u P, Ceña V (2012) Cofilin activation mediates Bax translocation to mitochondria during excitotoxic neuronal death. J Neurochem 120, 515-527.
126. Agrawal A,Min DH, Singh N, Zhu H, Birjiniuk A, von MG, Harris TJ, Xing D, Woolfenden SD, Sharp PA, Charest A, Bhatia S (2009) Functional delivery of siRNA in mice using dendriworms. ACS Nano 3, 2495-2504.
127. Mishra V, Mahor S, Rawat A, Gupta PN, Dubey P, Khatri K, Vyas SP (2006) Targeted brain delivery of AZT via transferrin anchored pegylated albumin nanoparticles. J Drug Target 14, 45-53.
128. Demeule M, Currie JC, Bertrand Y, Che C, Nguyen T, Regina A, Gabathuler R, Castaigne JP, Beliveau R (2008) Involvement of the low-density lipoprotein receptor-related protein in the transcytosis of the brain delivery vector angiopep-2. J Neurochem 106, 1534-1544.
129. Huang R, Ke W, Liu Y, Jiang C, Pei Y (2008) The use of lactoferrin as a ligand for targeting the polyamidoaminebased gene delivery system to the brain. Biomaterials 29, 238-246.
130. Kim ID, Lim CM, Kim JB, Nam HY, Nam K, Kim SW, Park JS, Lee JK (2010) Neuroprotection by biodegradable PAMAMester (e-PAM-R)-mediated HMGB1 siRNA delivery in primary cortical cultures and in the postischemic brain. J Control Release 142, 422-430.
131. Arribas AS, Moreno M, Bermejo E, Angeles Lorenzo M, Zapardiel A, Chicharro M (2009) Design and adaptation of miniaturized electrochemical devices integrating carbon nanotube-based sensors to commercial CE equipment. Electrophoresis 30, 3480-3488.
132. Keefer EW, Botterman BR, Romero MI, Rossi AF, Gross GW (2008) Carbon nanotube coating improves neuronal recordings. Nat Nanotechnol 3, 434-439.
133. Pantarotto D, Briand JP, Prato M, Bianco A (2004) Translocation of bioactive peptides across cell membranes by carbon nanotubes. Chem Commun (Camb), 16-17.
134. Kostarelos K, Bianco A, PratoM(2009) Promises, facts and challenges for carbon nanotubes in imaging and therapeutics. Nat Nanotechnol 4, 627-633.
135. Lovat V, Pantarotto D, Lagostena L, Cacciari B, Grandolfo M, Righi M, Spalluto G, Prato M, Ballerini L (2005) Carbon nanotube substrates boost neuronal electrical signaling. Nano Lett 5, 1107-1110.
136. Cellot G, Cilia E, Cipollone S, Rancic V, Sucapane A, Giordani S, Gambazzi L, Markram H, Grandolfo M, Scaini D, Gelain F, Casalis L, Prato M, Giugliano M, Ballerini L (2009) Carbon nanotubes might improve neuronal performance by favouring electrical shortcuts. Nat Nanotechnol 4, 126-133.
137. Malarkey EB, Fisher KA, Bekyarova E, Liu W, Haddon RC, ParpuraV(2009) Conductive single-walled carbon nanotube substrates modulate neuronal growth. Nano Lett 9, 264-268.
138. Donaldson K, Tran CL (2004) An introduction to the shortterm toxicology of respirable industrial fibres. Mutat Res 553, 5-9.
139. Iijima S, Yudasaka M, Yamada R, Bandow S, Suenaga K, Kokai F, Takahashi K (1999) Nano-aggregates of singlewalled graphitic carbon nano-horns. Chem Phys Lett 309, 165-170.
140. Ajima K, Yudasaka M, Murakami T, Maigne A, Shiba K, Iijima S (2005) Carbon nanohorns as anticancer drug carriers. Mol Pharm 2, 475-480.
141. Miyawaki J, Matsumura S, Yuge R, Murakami T, Sato S, Tomida A, Tsuruo T, Ichihashi T, Fujinami T, Irie H, Tsuchida K, Iijima S, Shiba K, Yudasaka M (2009) Biodistribution and ultrastructural localization of singlewalled carbon nanohorns determined in vivo with embedded Gd2O3 labels. ACS Nano 3, 1399-1406.